Preventing cardiovascular disease in women: an update

Nanette K Wenger1

  • 1Emory University School of Medicine, Grady Memorial Hospital, Emory Heart & Vascular Center, Atlanta, Georgia, USA. mwenger@emory.edu

Clinical Cardiology
|September 7, 2007
PubMed

Insights

Coronary heart disease (CHD) remains a leading cause of death for US women. Guidelines recommend lifestyle changes and medications, yet women are often underdiagnosed and undertreated for cardiovascular risk factors.

Area of Science:

  • Cardiology
  • Women's Health
  • Preventive Medicine

Background:

  • Coronary heart disease (CHD) is the primary cause of mortality for women in the United States.
  • American Heart Association (AHA) guidelines provide evidence-based recommendations for CHD prevention in women.
  • Key risk factors include smoking, inactivity, poor diet, dyslipidemia, hypertension, diabetes, and metabolic syndrome.

Purpose of the Study:

  • To summarize current recommendations for CHD prevention in women.
  • To highlight the role of lifestyle interventions and pharmacotherapy.
  • To address the underrecognition and undertreatment of cardiovascular risk in women.

Main Methods:

  • Review of American Heart Association (AHA) guidelines.
  • Analysis of risk factors contributing to CHD in women.
  • Discussion of lifestyle and pharmacologic interventions.
  • Consideration of new clinical trial findings relevant to women.

Main Results:

  • Lifestyle interventions significantly reduce CHD risk.
  • Many women require pharmacotherapy for hypertension, dyslipidemia, and diabetes.
  • High coronary risk in women is often underrecognized.
  • Women are frequently undertreated with statins and other therapies.

Conclusions:

  • Adherence to guidelines and timely intervention are crucial for reducing CHD mortality in women.
  • Addressing underdiagnosis and undertreatment is essential for improving cardiovascular outcomes.
  • Further research and clinical trial data specific to women may refine risk prediction and treatment strategies.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...